The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
ILD with a granulomatous component
Publications
Mesalazine-induced eosinophilic variant of Wegener's granulomatosis in an ulcerative colitis patient.
Journal of Ayub Medical College, Abbottabad : JAMC 2009 Oct-Dec;21;171-3 — 2009 Oct-Dec — 171-3
Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: a pediatric case report.
Journal of pediatric gastroenterology and nutrition 2005 Oct;41;479-82 — 2005 Oct — 479-82
Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations.
Inflammatory bowel diseases 2003 Sep;9;308-15 — 2003 Sep — 308-15